Author:
Olver Ian N.,Webster Lorraine K.,Bishop James F.,Stokes Kerrie H.
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Cancer Research,Pharmacology,Toxicology,Oncology
Reference25 articles.
1. Armand JP, Recondo G, Belehradek M, Gouyette A, Droz JP, DeForni M, Chabot GG (1989) Multiple weekly schedule flavone acetic acid phase I and pharmacokinetic studies (abstrac 981). Proc Am Assoc Cancer Res 30: 247
2. Bibby MC, Double JA, Phillips RM, Loadman PM (1987) Factors involved in the anti-cancer activity of the investigational agents LM985 (flavone acetic acid ester) and LM975 (flavone acetic acid). Br J Cancer 55: 159
3. Bissery M-C, Valeriote FA, Chabot GG, Crissman JD, Yost C, Corbett TH (1988) Flavone acetic acid (NSC 347 512)-induced DNA damage in Glasgow osteogenic sarcoma in vivo. Cancer Res 48: 1279
4. Brodfuehrer J, Valeriote F, Chan K, Heilbrun L, Corbett T (1990) Flavone acetic acid and plasma protein binding. Cancer Chemother Pharmacol 27: 27
5. Capolongo LS, Balconi G, Ubezio P, Giavazzi R, Taraboletti G, Regonesi A, Yoder OC, D'Incalci M (1987) Antiproliferative properties of flavone acetic acid (NSC 347 512) (LM 975), a new anticancer agent. Eur J Cancer Clin Oncol 23: 1529
Cited by
9 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献